Guardant Health
GH
#1003
Rank
NZ$42.43 B
Marketcap
NZ$316.20
Share price
1.75%
Change (1 day)
193.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$6.07

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$6.21. In 2025 the company made an earnings per share (EPS) of NZ-$5.89 an increase over its 2024 EPS that were of NZ-$6.33.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.073.05%
2025NZ-$5.89-7.02%
2024NZ-$6.33-16.82%
2023NZ-$7.61-33.13%
2022NZ-$11.3860%
2021NZ-$7.1155.04%
2020NZ-$4.59207.14%
2019NZ-$1.49-19.81%
2018NZ-$1.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$0.06399-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.36-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA